JP2010501160A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010501160A5 JP2010501160A5 JP2009524009A JP2009524009A JP2010501160A5 JP 2010501160 A5 JP2010501160 A5 JP 2010501160A5 JP 2009524009 A JP2009524009 A JP 2009524009A JP 2009524009 A JP2009524009 A JP 2009524009A JP 2010501160 A5 JP2010501160 A5 JP 2010501160A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- item
- cell
- composition
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83720906P | 2006-08-11 | 2006-08-11 | |
| US60/837,209 | 2006-08-11 | ||
| US11/836,645 | 2007-08-09 | ||
| US11/836,645 US7972602B2 (en) | 2006-08-11 | 2007-08-09 | Promiscuous HER-2/Neu CD4 T cell epitopes |
| PCT/US2007/075681 WO2008022019A2 (en) | 2006-08-11 | 2007-08-10 | Promiscuous her-2/neu cd4 t cell epitopes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010501160A JP2010501160A (ja) | 2010-01-21 |
| JP2010501160A5 true JP2010501160A5 (enExample) | 2011-09-08 |
| JP5189593B2 JP5189593B2 (ja) | 2013-04-24 |
Family
ID=39082993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009524009A Expired - Fee Related JP5189593B2 (ja) | 2006-08-11 | 2007-08-10 | 無差別ＨＥＲ−２／ＮｅｕＣＤ４Ｔ細胞エピトープ |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US7972602B2 (enExample) |
| EP (2) | EP2570422B1 (enExample) |
| JP (1) | JP5189593B2 (enExample) |
| CA (1) | CA2660178C (enExample) |
| ES (2) | ES2441252T3 (enExample) |
| HU (1) | HUE026977T2 (enExample) |
| PL (1) | PL2570422T3 (enExample) |
| WO (1) | WO2008022019A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017096247A1 (en) | 2015-12-04 | 2017-06-08 | Mayo Foundation For Medical Education And Research | Methods and vaccines for inducing immune responses to multiple different mhc molecules |
| US12247053B2 (en) | 2018-10-26 | 2025-03-11 | Saint Louis University | Peptides for inducing heterosubtypic influenza T cell responses |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4673641A (en) | 1982-12-16 | 1987-06-16 | Molecular Genetics Research And Development Limited Partnership | Co-aggregate purification of proteins |
| US5552534A (en) | 1991-08-22 | 1996-09-03 | The Trustees Of The University Of Pennsylvania | Non-Peptide peptidomimetics |
| US5550251A (en) | 1991-12-12 | 1996-08-27 | The Trustees Of The University Of Pennsylvania | Alicyclic peptidomimetics |
| US5801005A (en) | 1993-03-17 | 1998-09-01 | University Of Washington | Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated |
| US6160089A (en) | 1998-07-08 | 2000-12-12 | Mitsui Chemicals, Inc. | Method for secretory production of human growth hormone |
| JP4658423B2 (ja) | 1999-08-03 | 2011-03-23 | ザ オハイオ ステイト ユニバーシティ | Ｈｅｒ−２タンパク質に対する免疫反応性を増強するためのポリペプチドおよびポリヌクレオチド |
| AU2087401A (en) | 1999-12-10 | 2001-06-18 | Epimmune, Inc. | Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions |
| ATE507295T1 (de) | 2000-03-30 | 2011-05-15 | Dendreon Corp | Zusammensetzungen und verfahren für eine auf dendritischen zellen basierende immuntherapie |
| US20040121946A9 (en) * | 2000-12-11 | 2004-06-24 | John Fikes | Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions |
| JPWO2005007694A1 (ja) * | 2003-07-16 | 2007-09-20 | 株式会社グリーンペプタイド | ＨＥＲ２／ｎｅｕペプチドおよびその治療上の用途 |
| GB0427131D0 (en) * | 2004-12-10 | 2005-01-12 | Glaxosmithkline Biolog Sa | Novel combination |
-
2007
- 2007-08-09 US US11/836,645 patent/US7972602B2/en active Active
- 2007-08-10 JP JP2009524009A patent/JP5189593B2/ja not_active Expired - Fee Related
- 2007-08-10 PL PL12168585.3T patent/PL2570422T3/pl unknown
- 2007-08-10 WO PCT/US2007/075681 patent/WO2008022019A2/en not_active Ceased
- 2007-08-10 CA CA2660178A patent/CA2660178C/en active Active
- 2007-08-10 EP EP12168585.3A patent/EP2570422B1/en active Active
- 2007-08-10 HU HUE12168585A patent/HUE026977T2/en unknown
- 2007-08-10 EP EP07813984.7A patent/EP2054430B1/en active Active
- 2007-08-10 ES ES07813984.7T patent/ES2441252T3/es active Active
- 2007-08-10 ES ES12168585.3T patent/ES2561677T3/es active Active
-
2011
- 2011-05-31 US US13/149,408 patent/US8263757B2/en active Active
-
2012
- 2012-08-16 US US13/587,619 patent/US8658177B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023015335A (ja) | Ｒｓｖ ｆタンパク質突然変異体 | |
| CA2621414C (en) | Mmp-7 and adf derived tumour-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules | |
| JP2009506762A5 (enExample) | ||
| JP2010500037A5 (enExample) | ||
| JP2012510431A5 (enExample) | ||
| JP2019510465A5 (enExample) | ||
| JP2018511321A5 (enExample) | ||
| TW200413406A (en) | Peptides and drugs containing the same | |
| CA2393738A1 (en) | Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions | |
| JP2015506705A5 (enExample) | ||
| JP2022513019A (ja) | 新規の酸化還元酵素モチーフを有する免疫原性ペプチド | |
| JP2012516140A5 (enExample) | ||
| CA2962933A1 (en) | Use of hla genetic status to assess or select treatment of celiac disease | |
| JP2022532271A5 (enExample) | ||
| JP2025510320A (ja) | エピトープの組合せ及びその使用、ワクチン構築物、免疫応答を誘導する方法、エピトープを特定する方法 | |
| JP2012526519A5 (enExample) | ||
| Yazdanian et al. | Evaluation of cellular responses for a chimeric HBsAg-HCV core DNA vaccine in BALB/c mice | |
| JP2013521761A5 (enExample) | ||
| Reimann et al. | DNA vaccines expressing antigens with a stress protein‐capturing domain display enhanced immunogenicity | |
| JP2013513549A5 (enExample) | ||
| Vitalis et al. | Using the TAP component of the antigen-processing machinery as a molecular adjuvant | |
| JP2013540419A5 (enExample) | ||
| JP2013523082A5 (enExample) | ||
| Chen et al. | Ubiquitin conjugation of hepatitis B virus core antigen DNA vaccine leads to enhanced cell-mediated immune response in BALB/c mice | |
| Liu et al. | A mutant HBs antigen (HBsAg) 183–191 epitope elicits specific cytotoxic T lymphocytes in acute hepatitis B patients |